Quantcast
Home > Quotes > DARE
DARE

Dare Bioscience, Inc. Common Stock (DARE) Quote & Summary Data

$0.7495
*  
0.0345
4.83%
Get DARE Alerts
*Delayed - data as of Dec. 14, 2018  -  Find a broker to begin trading DARE now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    DARE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
6.375
Today's High / Low
$ 0.7495 / $ 0.70
Share Volume
69,515
50 Day Avg. Daily Volume
320,370
Previous Close
$ 0.715
52 Week High / Low
$ 3.59 / $ 0.701
Market Cap
8,560,910
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
2.08

Intraday Chart

Shares Traded

Share Volume:
69,515
50 Day Avg. Daily Volume:
320,370

Trading Range

The current last sale of $0.7495 is 6.92% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.7495 $ 3.59
 Low: $ 0.70 $ 0.701

Company Description (as filed with the SEC)

The terms "we," "us," "our," "Daré" or the "Company" refer collectively to Daré Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or the context otherwise requires. All information presented in this report is based on our fiscal year. Unless otherwise stated, references to particular years, quarters, months or periods refer to our fiscal years ending December 31 and the associated quarters, months and periods of those fiscal years. Overview We are a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's reproductive health. We are driven by a mission to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility.  ... More ...  


Risk Grade

Where does DARE fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.70
Open Date:
Dec. 14, 2018
Close Price:
$ 0.722
Close Date:
Dec. 14, 2018

Consensus Recommendation

Analyst Info